From the Qingdao Eye Hospital (D.L., L.T., X.W., F.Z., T.L., Y.D., P.L., D.L., D.S., M.C.), Shandong First Medical University, Qingdao, China; State Key Laboratory Cultivation Base (D.L., T.L., Y.D., P.L., D.L., M.C.), Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, China; School of Ophthalmology (D.L., L.T., X.W., T.L., Y.D., D.L., M.C.), Shandong First Medical University, Qingdao, China.
From the Qingdao Eye Hospital (D.L., L.T., X.W., F.Z., T.L., Y.D., P.L., D.L., D.S., M.C.), Shandong First Medical University, Qingdao, China; School of Ophthalmology (D.L., L.T., X.W., T.L., Y.D., D.L., M.C.), Shandong First Medical University, Qingdao, China.
Am J Ophthalmol. 2024 Oct;266:37-45. doi: 10.1016/j.ajo.2024.05.006. Epub 2024 May 11.
To evaluate the recurrence characteristics on optical coherence tomography and clinical outcomes after phototherapeutic keratectomy (PTK) or penetrating keratoplasty (PKP) in patients with Reis-Bücklers corneal dystrophy (RBCD).
Retrospective interventional case series.
Seventeen patients with RBCD (31 eyes, including 6 surgery-naïve eyes and 25 surgical eyes) received 44 surgical interventions from 1996 through 2022. PTK or PKP was performed as the initial surgical procedure. Significant recurrence was determined when best spectacle-corrected visual acuity decreased at least 2 lines with increased opacity in the superficial cornea. Repeated PTK or PTK on the corneal graft (CG-PTK) was considered if patients could not endure poor vision due to significant recurrence. Recurrence depth and annual increase in thickness of the central cornea and subepithelial deposits were assessed by anterior segment optical coherence tomography.
The mean follow-up time was 12.8 ± 8.5 years (range, 2.0-25.5 years). The mean logMAR best spectacle-corrected visual acuity improved from 1.24 ± 0.48 preoperatively to 0.27 ± 0.09 postoperatively in the initial PTK group (13 eyes, P < .001), from 1.84 ± 0.69 to 0.40 ± 0.13 in the PKP group (12 eyes, P < .001), from 1.04 ± 0.46 to 0.30 ± 0.07 in the repeated PTK group (12 times in 7 eyes, P < .001), and from 1.29 ± 0.43 to 0.39 ± 0.11 in the CG-PTK group (7 times in 5 eyes, P = .001). The median significant recurrence time was 27 months (95% confidence interval 23.9-30.1), 96 months (84.1-107.9), 31 months (28.8-33.1), and 24 months (19.8-28.2), respectively (P < .001). The depth of superficial deposits located between the epithelium and the anterior stroma was approximately 115 µm (85-159 µm). The annual thickening of subepithelial deposits was 14 ± 2 µm after initial PTK, 7 ± 3 µm after PKP, 14 ± 3 µm after repeated PTK, and 30 ± 11 µm after CG-PTK, compared to 4 ± 2 µm in surgery-naïve eyes (P = .002, .515, .002, <.001). The thickness of the central cornea increased by 15 ± 2 µm, 7 ± 2 µm, 15 ± 3 µm, and 31 ± 10 µm per year in the 4 surgery groups, respectively, compared to 5 ± 2 µm in surgery-naïve eyes (P = .001, .469, .001, <.001).
Better visual acuity can be achieved after PTK than PKP for treatment of RBCD. The annual thickening of subepithelial deposits may approximate an increase in central corneal thickness. The superficial distribution of subepithelial deposits makes it feasible to perform repeated PTK, even on the corneal allograft, for recurrent RBCD.
评估 Reis-Bücklers 角膜营养不良(RBCD)患者经光动力角膜切削术(PTK)或穿透性角膜移植术(PKP)治疗后的复发特征和临床结果。
回顾性干预性病例系列。
1996 年至 2022 年,17 名 RBCD 患者(31 只眼,包括 6 只手术初治眼和 25 只手术眼)接受了 44 次手术干预。PTK 或 PKP 作为初始手术。最佳矫正视力至少下降 2 行且浅层角膜混浊加重时,判断为显著复发。如果患者因显著复发而无法忍受视力不佳,可考虑再次行 PTK 或角膜移植片上的 PTK(CG-PTK)。通过眼前节光学相干断层扫描评估中央角膜和上皮下沉积物的复发深度和每年厚度增加。
平均随访时间为 12.8 ± 8.5 年(范围:2.0-25.5 年)。初始 PTK 组(13 只眼)的最佳矫正视力 logMAR 从术前的 1.24 ± 0.48 提高到术后的 0.27 ± 0.09(P <.001),PKP 组(12 只眼)从 1.84 ± 0.69 提高到 0.40 ± 0.13(P <.001),重复 PTK 组(7 只眼 12 次)从 1.04 ± 0.46 提高到 0.30 ± 0.07(P <.001),CG-PTK 组(5 只眼 7 次)从 1.29 ± 0.43 提高到 0.39 ± 0.11(P =.001)。显著复发时间中位数分别为 27 个月(95%置信区间:23.9-30.1)、96 个月(84.1-107.9)、31 个月(28.8-33.1)和 24 个月(19.8-28.2)(P <.001)。位于上皮和前基质之间的浅层沉积物的深度约为 115 µm(85-159 µm)。初次 PTK 后上皮下沉积物的年增厚量为 14 ± 2 µm,PKP 后为 7 ± 3 µm,重复 PTK 后为 14 ± 3 µm,CG-PTK 后为 30 ± 11 µm,而手术初治眼为 4 ± 2 µm(P =.002,.515,.002,<.001)。4 个手术组中央角膜厚度每年分别增加 15 ± 2 µm、7 ± 2 µm、15 ± 3 µm 和 31 ± 10 µm,而手术初治眼为 5 ± 2 µm(P =.001,.469,.001,<.001)。
与 PKP 相比,PTK 治疗 RBCD 可获得更好的视力。上皮下沉积物的年增厚量可能与中央角膜厚度的增加大致相当。上皮下沉积物的浅层分布使得即使是角膜移植物也可以进行重复 PTK,以治疗复发性 RBCD。